SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

Full list of Israeli high-tech funding rounds in 2025

Syremis raises $165 million Series A to take on schizophrenia and other severe mental illnesses

Iron Dome and Iron Beam maker Rafael moves closer to a possible IPO

Weapons as strategy: Israel’s defense industry steps into a larger global role

Buzz

Most popular

Daily

Weekly

1

Huang declares Israel Nvidia’s “second home” with record-breaking campus investment

2

Cyera raises $400 million at $9 billion valuation in Blackstone-led round

3

Vega raises $120 million Series B as two-year-old cyber startup hits $700 million valuation

4

Dell acquires AI data-infrastructure startup Dataloop in $120 million all-cash deal

5

“The acquisition of Armis marks a clear entry by ServiceNow into cybersecurity”

Eli ben Harush

1 stories about Eli ben Harush

Innovative treatment using an electronic device that diffuses light at a dedicated frequency to eliminate the fungus

Galil-based Israeli start-up Zero Candida reports 99.99% success rate in breakthrough Candida treatment, starts crowdfunding

21.03.23|Sponsored Content

In Moshav Dalton in the Galil Israeli start-up, Zero Candida has reported pre-clinical success in treating Candida, the fungal yeast infection affecting 75% of women worldwide. Trial results have proven 99.9999% eradication of the infection at an impressive speed. The company has recently started crowdfunding, inviting all Israelis to invest in the company. What’s the next stage towards launching the product? How can you share in Zero Candida’s success?